Russian researchers are taking a different approach in the search for new antibiotics. They are using genomics to investigate how some natural antimicrobials use ‘Trojan Horse’ tactics to trick their way into bacteria.
Fossilised amber may be a promising source of novel antibacterial compounds, scientists reported at the ACS Spring 2021 online meeting. This includes diterpenoids with activity against resistant bacteria including methicillin resistant Staphylococcus aureus (MRSA). Read the full article in C&I Magazine.
A class of metal-based anti-viral compounds can shield human cells from viruses and may also trap them to prevent viral spread, Australian researchers have found. Read the full story in C&I Magazine.
German researchers are working on how to make battery production more adaptable. They say their scalable production system can be tailored to handle more flexible batteries made in different formats and from different materials. Read the full article in C&I Magazine.
Researchers have succeeded in modelling a complex molecule associated with a congenital muscle wasting disease, which could help to develop future treatments. Read the full article in C&I Magazine.
The great hope for an Alzheimer’s treatment for 2021 – aducanumab –is a monoclonal antibody from Biogen that removes amyloid beta peptide, a hallmark of disease. There’s been no new approved Alzheimer’s treatment for decades, and the US FDA is set to review aducanumab in June. Read the full article in C&I Magazine.